Travaux scientifiques

Prof. Dr. Kayhan Ertürk

126 publications. La source de l’information est indiquée à côté de chaque publication.

Retour au profil

  1. Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15725-9 PMID 41691201 Texte intégral en libre accèsSource : OpenAlex

  2. Perioperative FLOT versus Definitive 50.4 Gy Chemoradiotherapy in Siewert II Esophagogastric Junction Adenocarcinoma: A Multicenter Retrospective Cohort Study

    Cancer Management and Research, 2026

    DOI 10.2147/cmar.s583473 PMID 42038552 Texte intégral en libre accèsSource : OpenAlex

  3. Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study

    Medicine, 2026

    DOI 10.1097/md.0000000000048711 PMID 42116366 Texte intégral en libre accèsSource : OpenAlex

  4. Prognostic value of PSMA PET–derived tumor volume in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide

    Cancer Imaging, 2026

    DOI 10.1186/s40644-026-01036-6 PMID 42063136 Texte intégral en libre accèsSource : OpenAlex

  5. Neoadjuvant anthracycline-free versus anthracycline-containing chemotherapy combined with dual HER2 blockade in HER2-positive breast cancer: a real-world comparative study

    Breast Cancer Research, 2026

    DOI 10.1186/s13058-026-02312-w PMID 42210329 Texte intégral en libre accèsSource : OpenAlex

  6. Efficacy and tolerability of CDK 4/6 inhibitors in HR-positive HER2-negative de novo metastatic breast cancer patients aged ≥ 70 years

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16430-3 PMID 42351034 Texte intégral en libre accèsSource : OpenAlex

  7. Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-61625-0 PMID 42457832 Texte intégral en libre accèsSource : OpenAlex

  8. Bevacizumab or Aflibercept in Combination with Second-Line FOLFIRI after Progression on FOLFOX Plus Bevacizumab in Metastatic Colorectal Cancer: A Comparative Study

    Journal of Cancer, 2026

    DOI 10.7150/jca.138530 PMID 42807710 Texte intégral en libre accèsSource : OpenAlex

  9. Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16667-y PMID 42693417 Texte intégral en libre accèsSource : OpenAlex

  10. Prognostic significance of pretreatment anemia in patients with advanced cutaneous melanoma

    Medical Research Journal, 2026

    DOI 10.5603/mrj.110156 Texte intégral en libre accèsSource : OpenAlex

  11. Prognostic Significance of Systemic Immune Inflammation Index (SII) and Systemic Inflammation Response Index (SIRI) in Patients with Locally Advanced Gastric Cancer Treated with Perioperative FLOT Therapy

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2025-12-7 Texte intégral en libre accèsSource : OpenAlex

  12. The Impact of KRAS Mutation on Treatment Response and Survival in Patients with Metastatic Lung Adenocarcinoma Receiving First-line Systemic Therapy

    Journal of Oncological Sciences, 2026

    DOI 10.37047/jos.galenos.2026.2026-5-4 Texte intégral en libre accèsSource : OpenAlex

  13. Distribution of adverse effects of immune checkpoint inhibitors and their impact on survival: some with better but some with worse survival

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-16954-8 Texte intégral en libre accèsSource : OpenAlex

  14. The effect of adding ovarian function suppression to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-positive breast cancer who have undergone neoadjuvant therapy: a single-center experience

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-17017-8 PMID 42786451 Texte intégral en libre accèsSource : OpenAlex

  15. Clinicopathological Characteristics of Patients with HR-Positive/HER2-Negative Metastatic Breast Cancer Experiencing Early Progression Within 6 Months of CDK4/6 Inhibitor Therapy

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.269433 Source : OpenAlex

  16. Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study

    Scientific Reports, 2025

    DOI 10.1038/s41598-025-29276-9 PMID 41315659 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  17. Factors affecting survival and prognosis in extensive stage small cell lung cancer

    BMC Pulmonary Medicine, 2025

    DOI 10.1186/s12890-025-03625-w PMID 40200252 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  18. Comparison of clinical and prognostic characteristics of patients with classic and AIDS-related Kaposi sarcoma: A single-center experience

    Medicine, 2025

    DOI 10.1097/md.0000000000043576 PMID 40760592 Texte intégral en libre accèsSource : OpenAlex

  19. Distribution of side effects of anti-EGFR treatments in patients with metastatic colorectal cancer and evaluation of their relationship with survival

    Anti-Cancer Drugs, 2025

    DOI 10.1097/cad.0000000000001755 PMID 40626459 1 citation (Europe PMC) Source : OpenAlex

  20. Bevacizumab Efficacy and Tolerability in Patients with Metastatic Platinum-Sensitive Ovarian Cancer Beyond Progression

    Cancer Management and Research, 2025

    DOI 10.2147/cmar.s531276 PMID 40861079 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  21. The Effect of Total Neoadjuvant Treatment on Pathological Response and Survival in Locally Advanced Rectal Cancer: A Single Center Experience

    Clinical Colorectal Cancer, 2025

    DOI 10.1016/j.clcc.2025.05.001 PMID 40537334 1 citation (Europe PMC) Source : OpenAlex

  22. Analysis of the impact of IMDC score parameters on patients with metastatic clear cell renal cell carcinoma

    Biomarkers in Medicine, 2025

    DOI 10.1080/17520363.2025.2589382 PMID 41243728 Source : OpenAlex

  23. Activation of YAP/TAZ by gut microbiota via Wnt/β-catenin signaling in cancer development

    Academia molecular biology and genomics., 2025

    DOI 10.20935/acadmolbiogen7642 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  24. Brain metastases during follow-up of patients with resected cutaneous melanoma

    Melanoma Research, 2025

    DOI 10.1097/cmr.0000000000001026 PMID 39903284 1 citation (OpenAlex) Source : OpenAlex

  25. Clinical significances of variations in main hematological parameters at the time of diagnosis in patients with small cell lung cancer

    Oncology in Clinical Practice, 2025

    DOI 10.5603/ocp.108418 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  26. Age-related Survival Declines in Turkish Patients with Cutaneous Melanoma: A Retrospective Analysis

    Dermatology Practical & Conceptual, 2025

    DOI 10.5826/dpc.1502a4936 PMID 40401870 Texte intégral en libre accèsSource : OpenAlex

  27. Sex Difference Has No Effect on Survival in Pancreatic Cancer

    Indian Journal of Surgical Oncology, 2025

    DOI 10.1007/s13193-025-02321-9 PMID 41726035 Texte intégral en libre accèsSource : OpenAlex

  28. Associations of Increasing Serum Lactate Dehydrogenase Levels With Chemotherapy Responsiveness and Survival in Patients With Extensive Disease Small Cell Lung Cancer

    American Journal of Therapeutics, 2025

    DOI 10.1097/mjt.0000000000001919 PMID 40965371 Source : OpenAlex

  29. Association of superior vena cava syndrome with small cell lung cancer

    Oncology in Clinical Practice, 2025

    DOI 10.5603/ocp.108793 Texte intégral en libre accèsSource : OpenAlex

  30. Evaluation of ixabepilone efficacy and tolerability in metastatic breast cancer

    Medicine, 2024

    DOI 10.1097/md.0000000000040649 PMID 39809199 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

  31. Timing of chemotherapy after diagnosis of small cell lung cancer

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2305062 PMID 38250790 2 citations (Europe PMC) Source : ORCID

  32. Prognostic significance of body mass index and serum albumin as the indicators of nutritional status in small cell lung cancer

    Postgraduate Medicine, 2024

    DOI 10.1080/00325481.2024.2328512 PMID 38456321 8 citations (Europe PMC) Source : ORCID

  33. Comorbidity in Small Cell Lung Cancer: Prognostic Impacts of Hypertension/Coronary Artery Disease, Diabetes Mellitus, and Chronic Obstructive Pulmonary Disease

    Cancer Investigation, 2024

    DOI 10.1080/07357907.2024.2310574 PMID 38299573 10 citations (OpenAlex) Source : OpenAlex

  34. Female Patients with Small Cell Lung Cancer Have Better Survival than Males with Extensive but Not Limited Disease

    Oncology Research and Treatment, 2024

    DOI 10.1159/000540244 PMID 38972307 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  35. Clinical significances of TTF-1, neuroendocrine (chromogranin, synaptophysin, CD56), and keratin (pancytokeratin, CK7, CK5/6) marker immunostaining in small cell lung cancer

    Clinical & Translational Oncology, 2024

    DOI 10.1007/s12094-024-03683-2 PMID 39212909 1 citation (OpenAlex) Source : OpenAlex

  36. A Modified H-index Calculated Using the Duration of Professional Experience and the Author's Significant Contribution to Publications

    Cureus, 2024

    DOI 10.7759/cureus.53274 PMID 38435880 Texte intégral en libre accèsSource : OpenAlex

  37. Preliminary outcomes of total (FLOT8) vs standart neoadjuvant (FLOT 4+4) therapy for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma:A propensity-matched comparison

    European Journal of Surgical Oncology, 2024

    DOI 10.1016/j.ejso.2023.107856 Source : OpenAlex

  38. Primary tumor SUVmax and ratio of SUVmax to primary tumor size on pretreatment 18F-FDG-PET/CT scan in small cell lung cancer

    Wiener klinische Wochenschrift, 2023

    DOI 10.1007/s00508-023-02160-0 PMID 36882606 7 citations (OpenAlex) Source : OpenAlex

  39. Melanoma publications do not increase as much as the incidence of melanoma in the last two decades

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_1722_22 PMID 38384070 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  40. Online public interest in smoking and lung cancer: A comparative study in Google Trends

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_276_22 PMID 38384027 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  41. Turkey’s contribution to cancer publication: Expected quantity, unsatisfactory quality

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_1291_20 PMID 37148012 Texte intégral en libre accèsSource : OpenAlex

  42. Ulceration vs. Mitosis in Cutaneous Melanoma: Which Is Superior for Predicting Prognosis Across Clinical Stages?

    Cancer Investigation, 2022

    DOI 10.1080/07357907.2022.2133139 PMID 36200765 2 citations (Europe PMC) Source : ORCID

  43. Trunk melanomas: no survival differences between lesion sites

    Postgraduate Medicine, 2022

    DOI 10.1080/00325481.2022.2080380 PMID 35584552 2 citations (Europe PMC) Source : ORCID

  44. Limb melanomas: acral melanomas have worse survival

    Journal of Dermatological Treatment, 2022

    DOI 10.1080/09546634.2021.1877248 PMID 33470132 7 citations (Europe PMC) Source : ORCID

  45. Major Histotypes in Skin Melanoma: Nodular and Acral Lentiginous Melanomas Are Poor Prognostic Factors for Relapse and Survival

    American Journal of Dermatopathology, 2022

    DOI 10.1097/dad.0000000000002264 PMID 35925149 18 citations (OpenAlex) Source : OpenAlex

  46. Cutaneous melanoma survival rates of the elderly are not worse than those of the young, yet they have some specific differences

    Journal of Cancer Research and Therapeutics, 2022

    DOI 10.4103/jcrt.jcrt_815_21 PMID 37147952 7 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

  47. Breast cancer patients are diagnosed at younger ages in Turkey: a comparative study

    Irish Journal of Medical Science (1971 -), 2022

    DOI 10.1007/s11845-022-03136-1 PMID 35999485 3 citations (OpenAlex) Source : OpenAlex

  48. Median Age of Cutaneous Melanoma Presentation in Turkey from a Single Tertiary Center Is Younger Than Other Western Countries

    Indian Journal of Surgery, 2022

    DOI 10.1007/s12262-022-03566-2 1 citation (OpenAlex) Source : OpenAlex

  49. Neither the presence nor the severity of hyponatremia affected the outcome of the patients with small cell lung cancer

    Irish Journal of Medical Science (1971 -), 2022

    DOI 10.1007/s11845-022-03199-0 PMID 36279041 1 citation (OpenAlex) Source : OpenAlex

  50. Seasons Influence Diagnosis of Breast Cancer in Turkey

    Indian Journal of Surgery, 2022

    DOI 10.1007/s12262-021-03261-8 Source : OpenAlex